FindTrial
Sign In

Comprehensive Geriatric Assessment(CGA) for guiding the treatment in older adults with newly diagnosed multiple myeloma: a prospective, observational and single-arm multicenter study

Comprehensive Geriatric Assessment(CGA) for guiding the treatment in older adults with newly diagnosed multiple myeloma: a prospective, observational and single-arm multicenter study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050220
Enrollment
Unknown
Registered
2021-08-22
Start date
2021-09-10
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

case group:Nil

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult males and females aged 65 years or above; 2. Multiple myeloma was first diagnosed without treatment; 3. Ask the informed consent of patients and their families to participate in the research voluntarily.

Exclusion criteria

Exclusion criteria: 1.Patients with prior history of hematologic or solid tumors treated with radiotherapy or chemotherapy; 2.Failure to obtain signed informed consent.

Design outcomes

Primary

MeasureTime frame
Objective Response Rate on induction therapy;—

Secondary

MeasureTime frame
Overall survival;Progression-free survival;Early Mortality;Treatment discontinuation;Non-hematological adverse events ( AEs >= 3 );hematological adverse events ( AEs >= 3 );Duration of response;—

Countries

China

Contacts

Public ContactJin Fengyan

The First Hospital of Jilin University

fengyanjin@jlu.edu.cn+86 138 4498 9638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026